Related Experiment Videos
The medical treatment of patients presenting with intermittent claudication secondary to atherosclerosis
1Department of Surgery, Guy's Hospital, London, UK.
Insights
Peripheral vascular disease impacts many seniors, often without symptoms. Secondary prevention of cardiovascular disease, including risk factor modification and aspirin, is crucial for managing this condition.
Area of Science:
- Vascular Medicine
- Cardiovascular Health
- Geriatrics
Background:
- Peripheral vascular disease (PVD) is prevalent in the elderly population.
- Symptomatic cases requiring intervention are limited, often focusing on suprainguinal vessel disease.
- Traditional management includes smoking cessation and exercise.
Purpose of the Study:
- To emphasize the importance of secondary cardiovascular disease prevention in patients with peripheral vascular disease.
- To highlight the need for comprehensive risk factor assessment and management.
- To advocate for aspirin prescription in eligible patients.
Main Methods:
- Review of current clinical advice for peripheral vascular disease management.
- Emphasis on thorough assessment of cardiovascular risk factors.
- Consideration of lipid status and other modifiable risk factors.
Main Results:
- Secondary prevention strategies are vital for elderly patients with PVD.
- Risk factor modification, including lipid management, is recommended.
- Aspirin therapy should be considered for all tolerated cases.
Conclusions:
- Comprehensive cardiovascular risk factor management is essential for elderly PVD patients.
- Aspirin offers secondary prevention benefits for tolerated patients.
- Integrated care addressing both PVD and overall cardiovascular health is necessary.
Abstract:
Peripheral vascular disease affects a large number of elderly people but is symptomatic in only a few cases. Most of these will not be considered for surgical or radiological revascularisation procedures unless their disease affects the suprainguinal vessels. The traditional advice to stop smoking and keep walking is important but, in addition, thought should be given to the secondary prevention of cardiovascular disease in these patients. Thorough assessment and modification of their risk factors, including their lipid status, should be performed and aspirin should be prescribed to all patients who can tolerate it.